Clinical Characteristics and Death Risk Factors of Severe Sepsis in Children

Ying Zhang1, Buqing Cao2, Weihong Cao3

  • 1Department of Neonatology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei 441000, China.

Insights

Severe sepsis in children is a critical condition with rapid progression. Key indicators like serum lactic acid, PCIS, and organ involvement significantly impact mortality in pediatric intensive care unit patients.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Systemic inflammatory response

Background:

  • Sepsis, a systemic inflammatory response syndrome, poses a significant threat to children, often leading to severe outcomes and high mortality rates in pediatric intensive care units (PICUs).
  • Septic shock, characterized by circulatory dysfunction, presents with rapid onset and multi-organ involvement, complicating diagnosis and treatment.
  • Systemic Inflammatory Response Syndrome (SIRS) contributes to approximately one million deaths globally each year, highlighting the urgent need for effective management strategies.

Purpose of the Study:

  • To investigate the clinical characteristics of severe sepsis in children admitted to a PICU.
  • To identify risk factors associated with mortality in pediatric severe sepsis cases.
  • To analyze the relationship between specific clinical indicators and patient outcomes.

Main Methods:

  • Retrospective analysis of 65 pediatric sepsis cases admitted to a PICU.
  • Evaluation of clinical data, focusing on pathogenesis and treatment of septic shock.
  • Assessment of serum lactic acid levels, Pediatric Index of Critical Illness Score (PCIS), and Multiple Organ Dysfunction Syndrome (MODS) as potential risk factors.

Main Results:

  • The study identified significant clinical characteristics of severe sepsis in the pediatric population.
  • Serum lactic acid levels, PCIS, and the extent of organ involvement in MODS were found to be interrelated.
  • These factors demonstrated a notable association with the mortality rates in children suffering from severe sepsis.

Conclusions:

  • Clinical indicators such as serum lactic acid, PCIS, and MODS are critical in assessing the severity and predicting outcomes in pediatric sepsis.
  • Understanding these risk factors is crucial for timely intervention and improving survival rates in critically ill children.
  • Further research into the interplay of these factors can refine treatment protocols for severe sepsis in pediatric patients.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
10
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
11
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
510
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.6K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
140